Skip to main content
. Author manuscript; available in PMC: 2018 Aug 30.
Published in final edited form as: Am J Transplant. 2015 Mar;15(3):659–667. doi: 10.1111/ajt.13099

Figure 1. Cold ischemia time, before and after implementation of Share-35.

Figure 1

Median (IQR) CIT was 6.0 (4.7–7.6) hours pre-Share35 and 6.0 (4.8–7.8) hours post-Share35. There was no statistically significant difference in CIT per ranksum test (p=0.8). For the sake of illustration, outlier points with > 20 hours CIT are omitted (N=30 pre-Share35, N=38 post-Share35).